Insider filing · RXST
Jesse Anderson Corley bought $939K of RxSight (RXST)
Executed Nov 12 2024, disclosed Nov 14 2024, 2 days later.
Value, as filed
$939K
20,771 sh across 3 lots
Executed
Nov 12 2024
the trade date, as filed
Disclosed
Nov 14 2024
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
-15.6%
-18.4% from execution
Over the 21 trading sessions from the disclosed entry session (Nov 14 2024), the stock returned -15.6% (delay-adjusted); from the execution session (Nov 12 2024), -18.4%. Derived: entry at the session's open, exit at the close 20 sessions later.
The filer
JC
Jesse Anderson Corley
Director
profile →
Jesse Anderson Corley (Director) filed 1 Form 4 report in the past 24 months (1 purchase, 0 sales), most often in RXST. Across 1 priced purchase filing, the average 21-session return was -18.4% from execution and -15.6% from disclosure (delay-adjusted; derived). The largest single filing was $939K of RXST (20,771 sh across 3 lots, as filed), executed Nov 12 2024.
The name
RXST
RXST
RXST · 18 filings in 24 months
ticker →
Insider filings, newest first→
View the original filing at www.sec.gov→